TreeWAS – Variant ID: rs4821083

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z86.7 Personal history of diseases of the circulatory system	0.000	0.868	0.132
Z95.5 Presence of coronary angioplasty implant and graft	0.000	0.903	0.097
I21.0 Acute transmural myocardial infarction of anterior wall	0.000	0.982	0.018
H40.0 Glaucoma suspect	0.000	0.985	0.015
C67.9 Bladder, unspecified	0.000	0.988	0.012
H04.5 Stenosis and insufficiency of lachrymal passages	0.012	0.988	0.000
H50.0 Convergent concomitant strabismus	0.000	0.989	0.011
C67 Malignant neoplasm of bladder	0.000	0.990	0.010
C67.1 Dome of bladder	0.000	0.991	0.009
C67.4 Posterior wall of bladder	0.000	0.991	0.009
C67.0 Trigone of bladder	0.000	0.991	0.009
C67.8 Overlapping lesion of bladder	0.000	0.992	0.008
C67.3 Anterior wall of bladder	0.000	0.992	0.008
Y40.0 Penicillins	0.008	0.992	0.000
Y40 Systemic antibiotics	0.008	0.992	0.000
C67.7 Urachus	0.000	0.992	0.008
C67.2 Lateral wall of bladder	0.000	0.993	0.007
Y40.9 Systemic antibiotic, unspecified	0.007	0.993	0.000
Z95.0 Presence of cardiac pacemaker	0.000	0.993	0.007
Y40.8 Other systemic antibiotics	0.007	0.993	0.000
N85.2 Hypertrophy of uterus	0.007	0.993	0.000
C67.6 Ureteric orifice	0.000	0.993	0.007
C18.2 Ascending colon	0.007	0.993	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.007	0.993	0.000
C67.5 Bladder neck	0.000	0.993	0.007
C18.4 Transverse colon	0.007	0.993	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.007	0.993	0.000
Y52 Agents primarily affecting the cardiovascular system	0.006	0.994	0.000
Y40.7 Antifungal antibiotics, systemically used	0.006	0.994	0.000
Y53.4 Other laxatives	0.006	0.994	0.000
C18 Malignant neoplasm of colon	0.006	0.994	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.006	0.994	0.000
Y45.0 Opioids and related analgesics	0.006	0.994	0.000
Y40.6 Rifamycins	0.006	0.994	0.000
Y40.4 Tetracyclines	0.006	0.994	0.000
Y40.2 Chloramphenicol group	0.006	0.994	0.000
C18.0 Caecum	0.006	0.994	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.006	0.994	0.000
Y40.5 Aminoglycosides	0.006	0.994	0.000
H50 Other strabismus	0.000	0.994	0.006
Y53.1 Other antacids and anti-gastric-secretion drugs	0.006	0.994	0.000
Z86.5 Personal history of other mental and behavioural disorders	0.000	0.994	0.006
Y40.3 Macrolides	0.006	0.994	0.000
Y52.1 Calcium-channel blockers	0.006	0.994	0.000
Z95 Presence of cardiac and vascular implants and grafts	0.000	0.994	0.006
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.006	0.994	0.000
Z86 Personal history of certain other diseases	0.000	0.994	0.006
Y57 Other and unspecified drugs and medicaments	0.006	0.994	0.000
Z85.5 Personal history of malignant neoplasm of urinary tract	0.000	0.994	0.006
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.006	0.994	0.000
Y49.5 Other antipsychotics and neuroleptics	0.006	0.994	0.000
I67.9 Cerebrovascular disease, unspecified	0.000	0.994	0.006
H40 Glaucoma	0.000	0.994	0.006
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.006	0.994	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.005	0.994	0.000
Z86.3 Personal history of endocrine, nutritional and metabolic diseases	0.000	0.994	0.005
C18.8 Overlapping lesion of colon	0.005	0.995	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.005	0.995	0.000
Y57.8 Other drugs and medicaments	0.005	0.995	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.005	0.995	0.000
C18.1 Appendix	0.005	0.995	0.000
H40.8 Other glaucoma	0.000	0.995	0.005
H50.9 Strabismus, unspecified	0.000	0.995	0.005
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.005	0.995	0.000
Y53.7 Emetics	0.005	0.995	0.000
Y53.6 Antidiarrhoeal drugs	0.005	0.995	0.000
Y53.5 Digestants	0.005	0.995	0.000
Y53.3 Saline and osmotic laxatives	0.005	0.995	0.000
Y53.2 Stimulant laxatives	0.005	0.995	0.000
Y53.0 Histamine H2-receptor antagonists	0.005	0.995	0.000
C18.6 Descending colon	0.005	0.995	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.005	0.995	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.005	0.995	0.000
C18.5 Splenic flexure	0.005	0.995	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.005	0.995	0.000
H50.2 Vertical strabismus	0.000	0.995	0.005
Y58 Bacterial vaccines	0.005	0.995	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.005	0.995	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.005	0.995	0.000
Y49.2 Other and unspecified antidepressants	0.005	0.995	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.005	0.995	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.005	0.995	0.000
Y52.7 Peripheral vasodilators	0.005	0.995	0.000
Y59 Other and unspecified vaccines and biological substances	0.005	0.995	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.005	0.995	0.000
Y48 Anaesthetics and therapeutic gases	0.005	0.995	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.005	0.995	0.000
C18.3 Hepatic flexure	0.005	0.995	0.000
Y56.3 Emollients, demulcents and protectants	0.005	0.995	0.000
Y49.9 Psychotropic drug, unspecified	0.005	0.995	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.005	0.995	0.000
Y49.7 Psychostimulants with abuse potential	0.005	0.995	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.005	0.995	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.005	0.995	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.005	0.995	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.005	0.995	0.000
H50.5 Heterophoria	0.000	0.995	0.005
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.005	0.995	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.005	0.995	0.000
H50.4 Other and unspecified heterotropia	0.000	0.995	0.005
Y57.6 Other diagnostic agents	0.005	0.995	0.000
Y57.5 X-ray contrast media	0.005	0.995	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.005	0.995	0.000
H50.8 Other specified strabismus	0.000	0.995	0.004
H50.6 Mechanical strabismus	0.000	0.995	0.004
H50.3 Intermittent heterotropia	0.000	0.995	0.004
H40.2 Primary angle-closure glaucoma	0.000	0.995	0.005
Y56.9 Topical agent, unspecified	0.004	0.996	0.000
Y56.8 Other topical agents	0.004	0.996	0.000
Y56.7 Dental drugs, topically applied	0.004	0.996	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.004	0.996	0.000
Y56.5 Ophthalmological drugs and preparations	0.004	0.996	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.004	0.996	0.000
Y56.2 Local astringents and local detergents	0.004	0.996	0.000
Y56.1 Antipruritics	0.004	0.996	0.000
Y57.7 Vitamins, not elsewhere classified	0.004	0.996	0.000
Y57.4 Pharmaceutical excipients	0.004	0.996	0.000
Y57.3 Alcohol deterrents	0.004	0.996	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.004	0.996	0.000
Y57.1 Lipotropic drugs	0.004	0.996	0.000
Y57.0 Appetite depressants [anorectics]	0.004	0.996	0.000
R10.3 Pain localised to other parts of lower abdomen	0.000	0.996	0.004
I47.2 Ventricular tachycardia	0.000	0.996	0.004
H40.6 Glaucoma secondary to drugs	0.000	0.996	0.004
H40.3 Glaucoma secondary to eye trauma	0.000	0.996	0.004
Y46.4 Iminostilbenes	0.004	0.996	0.000
Y48.4 Anaesthetic, unspecified	0.004	0.996	0.000
M65.94 Synovitis and tenosynovitis, unspecified (Hand)	0.004	0.996	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.004	0.996	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.004	0.996	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.004	0.996	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.004	0.996	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.004	0.996	0.000
Y51.0 Anticholinesterase agents	0.004	0.996	0.000
Y44 Agents primarily affecting blood constituents	0.004	0.996	0.000
C25.0 Head of pancreas	0.000	0.996	0.004
L91.0 Keloid scar	0.004	0.996	0.000
Z95.9 Presence of cardiac and vascular implant and graft, unspecified	0.000	0.996	0.004
Y41.0 Sulphonamides	0.004	0.996	0.000
C25.9 Pancreas, unspecified	0.000	0.996	0.004
Y41.1 Antimycobacterial drugs	0.004	0.996	0.000
S02.20 Fracture of nasal bones (closed)	0.000	0.996	0.004
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.004	0.996	0.000
C25 Malignant neoplasm of pancreas	0.000	0.996	0.004
Y46.8 Antispasticity drugs	0.004	0.996	0.000
Y46.7 Anti-Parkinsonism drugs	0.004	0.996	0.000
Y46.6 Other and unspecified antiepileptics	0.004	0.996	0.000
Y46.5 Valproic acid	0.004	0.996	0.000
Y46.3 Deoxybarbiturates	0.004	0.996	0.000
Y46.1 Oxazolidinediones	0.004	0.996	0.000
Y46.0 Succinimides	0.004	0.996	0.000
Y50.9 Central nervous system stimulant, unspecified	0.004	0.996	0.000
Y50.8 Other central nervous system stimulants	0.004	0.996	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.004	0.996	0.000
Y50.1 Opioid receptor antagonists	0.004	0.996	0.000
Y50.0 Analeptics	0.004	0.996	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.004	0.996	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.004	0.996	0.000
Y55.5 Anticommon cold drugs	0.004	0.996	0.000
Y55.4 Expectorants	0.004	0.996	0.000
Y55.3 Antitussives	0.004	0.996	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.004	0.996	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.004	0.996	0.000
Y55.0 Oxytocic drugs	0.004	0.996	0.000
Y58.9 Other and unspecified bacterial vaccines	0.004	0.996	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.004	0.996	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.004	0.996	0.000
Y58.5 Diphtheria vaccine	0.004	0.996	0.000
Y58.4 Tetanus vaccine	0.004	0.996	0.000
Y58.3 Plague vaccine	0.004	0.996	0.000
Y58.2 Cholera vaccine	0.004	0.996	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.004	0.996	0.000
Y58.0 BCG vaccine	0.004	0.996	0.000
H40.5 Glaucoma secondary to other eye disorders	0.000	0.996	0.004
C25.2 Tail of pancreas	0.000	0.996	0.004
H40.9 Glaucoma, unspecified	0.000	0.996	0.004
Y59.9 Vaccine or biological substance, unspecified	0.004	0.996	0.000
Y59.8 Other specified vaccines and biological substances	0.004	0.996	0.000
Y59.2 Protozoal vaccines	0.004	0.996	0.000
Y59.1 Rickettsial vaccines	0.004	0.996	0.000
Y59.0 Viral vaccines	0.004	0.996	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.004	0.996	0.000
Y41.5 Antiviral drugs	0.004	0.996	0.000
Y41.4 Anthelminthics	0.004	0.996	0.000
Y41.3 Other antiprotozoal drugs	0.004	0.996	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.004	0.996	0.000
Y48.5 Therapeutic gases	0.004	0.996	0.000
Y48.1 Parenteral anaesthetics	0.004	0.996	0.000
Y48.0 Inhaled anaesthetics	0.004	0.996	0.000
Y57.9 Drug or medicament, unspecified	0.004	0.996	0.000
Y45.4 Antirheumatics	0.004	0.996	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.004	0.996	0.000
Y59.3 Immunoglobulin	0.003	0.996	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.003	0.996	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.003	0.996	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.003	0.996	0.000
Y47.4 Bromine compounds	0.003	0.996	0.000
Y47.3 Paraldehyde	0.003	0.996	0.000
Y47.2 Chloral derivatives	0.003	0.996	0.000
Y47.0 Barbiturates, not elsewhere classified	0.003	0.996	0.000
H40.4 Glaucoma secondary to eye inflammation	0.000	0.996	0.003
J43.9 Emphysema, unspecified	0.004	0.996	0.000
Y45.8 Other analgesics and antipyretics	0.003	0.996	0.000
B96.3 Haemophilus influenzae [H. influenzae] as the cause of diseases classified to other chapters	0.000	0.996	0.004
Y46.2 Hydantoin derivatives	0.003	0.996	0.000
J20.9 Acute bronchitis, unspecified	0.003	0.997	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
Y48.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
C25.1 Body of pancreas	0.000	0.997	0.003
R19.0 Intra-abdominal and pelvic swelling, mass and lump	0.000	0.997	0.003
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.003	0.997	0.000
Z95.2 Presence of prosthetic heart valve	0.000	0.997	0.003
Y47.1 Benzodiazepines	0.003	0.997	0.000
Y48.3 Local anaesthetics	0.003	0.997	0.000
N31.9 Neuromuscular dysfunction of bladder, unspecified	0.000	0.997	0.003
Y44.9 Other and unspecified agents affecting blood constituents	0.003	0.997	0.000
Y44.7 Plasma substitutes	0.003	0.997	0.000
Y44.6 Natural blood and blood products	0.003	0.997	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.003	0.997	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.997	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.003	0.997	0.000
S02.80 Fractures of other skull and facial bones (closed)	0.000	0.997	0.003
Y44.5 Thrombolytic drugs	0.003	0.997	0.000
Y45.5 4-Aminophenol derivatives	0.003	0.997	0.000
Z86.1 Personal history of infectious and parasitic diseases	0.000	0.997	0.003
K80.5 Calculus of bile duct without cholangitis or cholecystitis	0.000	0.997	0.003
C25.8 Overlapping lesion of pancreas	0.000	0.997	0.003
C25.7 Other parts of pancreas	0.000	0.997	0.003
C25.4 Endocrine pancreas	0.000	0.997	0.003
C25.3 Pancreatic duct	0.000	0.997	0.003
H50.1 Divergent concomitant strabismus	0.000	0.997	0.003
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
Y45.2 Propionic acid derivatives	0.003	0.997	0.000
Y54.9 Mineral salts, not elsewhere classified	0.003	0.997	0.000
Y54.7 Agents affecting calcification	0.003	0.997	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.003	0.997	0.000
Y54.5 Other diuretics	0.003	0.997	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.003	0.997	0.000
Y54.0 Mineralocorticoids	0.003	0.997	0.000
Y54.4 Loop [high-ceiling] diuretics	0.003	0.997	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.003	0.997	0.000
A04.8 Other specified bacterial intestinal infections	0.000	0.997	0.003
S02.2 Fracture of nasal bones	0.000	0.997	0.003
J36 Peritonsillar abscess	0.003	0.997	0.000
M07.30 Other psoriatic arthropathies (Multiple sites)	0.000	0.997	0.003
H25.8 Other senile cataract	0.000	0.997	0.003
Y54.8 Agents affecting uric acid metabolism	0.002	0.997	0.000
Y45.1 Salicylates	0.002	0.997	0.000
L73.2 Hidradenitis suppurativa	0.003	0.997	0.000
H66.9 Otitis media, unspecified	0.000	0.997	0.003
S02.8 Fractures of other skull and facial bones	0.000	0.997	0.002
K56.5 Intestinal adhesions [bands] with obstruction	0.000	0.997	0.003
N90.8 Other specified noninflammatory disorders of vulva and perineum	0.000	0.998	0.002
H40-H42 Glaucoma	0.000	0.998	0.002
H35.3 Degeneration of macula and posterior pole	0.000	0.998	0.002
Z98.8 Other specified postsurgical states	0.002	0.998	0.000
C64-C68 Malignant neoplasms of urinary tract	0.000	0.998	0.002
A63.0 Anogenital (venereal) warts	0.002	0.998	0.000
H04.2 Epiphora	0.002	0.998	0.000
Y43 Primarily systemic agents	0.002	0.998	0.000
Z95.3 Presence of xenogenic heart valve	0.000	0.998	0.002
E14.3 With ophthalmic complications	0.002	0.998	0.000
H60.1 Cellulitis of external ear	0.002	0.998	0.000
Y42.5 Other oestrogens and progestogens	0.000	0.998	0.002
J15.4 Pneumonia due to other streptococci	0.002	0.998	0.000
J44.8 Other specified chronic obstructive pulmonary disease	0.002	0.998	0.000
Y44.2 Anticoagulants	0.002	0.998	0.000
H04 Disorders of lachrymal system	0.002	0.998	0.000
S02.21 Fracture of nasal bones (open)	0.000	0.998	0.002
C18.9 Colon, unspecified	0.002	0.998	0.000
H81.0 Meniere's disease	0.000	0.998	0.002
K56.7 Ileus, unspecified	0.000	0.998	0.002
Y54.3 Benzothiadiazine derivatives	0.002	0.998	0.000
K62.6 Ulcer of anus and rectum	0.002	0.998	0.000
S62.30 Fracture of other metacarpal bone (closed)	0.002	0.998	0.000
R47.0 Dysphasia and aphasia	0.000	0.998	0.002
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified	0.002	0.998	0.000
K22.5 Diverticulum of oesophagus, acquired	0.000	0.998	0.002
S12.70 Multiple fractures of cervical spine (closed)	0.002	0.998	0.000
H60.0 Abscess of external ear	0.002	0.998	0.000
S02.81 Fractures of other skull and facial bones (open)	0.000	0.998	0.002
C65 Malignant neoplasm of renal pelvis	0.000	0.998	0.002
H60 Otitis externa	0.002	0.998	0.000
Y43.4 Immunosuppressive agents	0.002	0.998	0.000
H42 Glaucoma in diseases classified elsewhere	0.000	0.998	0.002
S05.8 Other injuries of eye and orbit	0.000	0.998	0.002
C68 Malignant neoplasm of other and unspecified urinary organs	0.000	0.998	0.002
S72.20 Subtrochanteric fracture (closed)	0.000	0.998	0.002
M23.20 Derangement of meniscus due to old tear or injury (Multiple sites)	0.000	0.998	0.002
K35.0 Acute appendicitis with generalised peritonitis	0.000	0.998	0.002
Y43.9 Primarily systemic agent, unspecified	0.002	0.998	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.002	0.998	0.000
Y43.6 Enzymes, not elsewhere classified	0.002	0.998	0.000
Y43.5 Acidifying and alkalising agents	0.002	0.998	0.000
Y43.2 Antineoplastic natural products	0.002	0.998	0.000
S12.7 Multiple fractures of cervical spine	0.002	0.998	0.000
S02 Fracture of skull and facial bones	0.000	0.998	0.002
C18.7 Sigmoid colon	0.002	0.998	0.000
H04.6 Other changes in lachrymal passages	0.002	0.998	0.000
H04.0 Dacryoadenitis	0.002	0.998	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.001	0.998	0.001
S12.20 Fracture of other specified cervical vertebra (closed)	0.002	0.998	0.000
H60.2 Malignant otitis externa	0.002	0.998	0.000
H60.4 Cholesteatoma of external ear	0.002	0.998	0.000
S12.2 Fracture of other specified cervical vertebra	0.002	0.998	0.000
H35.7 Separation of retinal layers	0.000	0.998	0.002
C66 Malignant neoplasm of ureter	0.000	0.998	0.002
S12 Fracture of neck	0.002	0.998	0.000
Y43.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
Z86.2 Personal history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.000	0.998	0.001
H18.5 Hereditary corneal dystrophies	0.000	0.998	0.002
S02.6 Fracture of mandible	0.000	0.998	0.002
J43 Emphysema	0.002	0.998	0.000
C16.3 Pyloric antrum	0.002	0.998	0.000
M07.3 Other psoriatic arthropathies	0.000	0.998	0.002
S12.9 Fracture of neck, part unspecified	0.002	0.998	0.000
M77.47 Metatarsalgia-Ankle/Foot	0.000	0.998	0.002
H61.0 Perichondritis of external ear	0.002	0.998	0.000
S02.3 Fracture of orbital floor	0.000	0.998	0.002
S12.90 Fracture of neck, part unspecified (closed)	0.002	0.998	0.000
C68.9 Urinary organ, unspecified	0.000	0.998	0.001
C68.8 Overlapping lesion of urinary organs	0.000	0.998	0.001
C68.1 Paraurethral glands	0.000	0.998	0.001
C68.0 Urethra	0.000	0.998	0.001
H42.8 Glaucoma in other diseases classified elsewhere	0.000	0.998	0.001
H42.0 Glaucoma in endocrine, nutritional and metabolic diseases	0.000	0.998	0.001
H60.9 Otitis externa, unspecified	0.002	0.998	0.000
Z95.1 Presence of aortocoronary bypass graft	0.000	0.998	0.002
H04.8 Other disorders of lachrymal system	0.002	0.998	0.000
N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere	0.000	0.998	0.002
J20 Acute bronchitis	0.002	0.998	0.000
S12.71 Multiple fractures of cervical spine (open)	0.002	0.998	0.000
F45.8 Other somatoform disorders	0.002	0.998	0.000
H04.9 Disorder of lachrymal system, unspecified	0.002	0.998	0.000
H04.3 Acute and unspecified inflammation of lachrymal passages	0.002	0.998	0.000
H60.8 Other otitis externa	0.002	0.998	0.000
J15.7 Pneumonia due to Mycoplasma pneumoniae	0.002	0.998	0.000
S13.4 Sprain and strain of cervical spine	0.002	0.998	0.000
S02.60 Fracture of mandible (closed)	0.000	0.998	0.002
J43.8 Other emphysema	0.002	0.998	0.000
Y43.1 Antineoplastic antimetabolites	0.002	0.998	0.000
C16 Malignant neoplasm of stomach	0.002	0.998	0.000
A87.9 Viral meningitis, unspecified	0.000	0.998	0.002
H60.3 Other infective otitis externa	0.002	0.998	0.000
K56.4 Other impaction of intestine	0.000	0.998	0.002
S02.1 Fracture of base of skull	0.000	0.998	0.002
J15 Bacterial pneumonia, not elsewhere classified	0.002	0.998	0.000
C16.9 Stomach, unspecified	0.002	0.998	0.000
H04.4 Chronic inflammation of lachrymal passages	0.001	0.998	0.000
Y42.9 Other and unspecified hormone antagonists	0.001	0.998	0.001
Y42.4 Oral contraceptives	0.001	0.998	0.001
Y42.1 Thyroid hormones and substitutes	0.001	0.998	0.001
H35.8 Other specified retinal disorders	0.000	0.998	0.002
H60.5 Acute otitis externa, non-infective	0.002	0.998	0.000
K35.1 Acute appendicitis with peritoneal abscess	0.000	0.998	0.002
N90.5 Atrophy of vulva	0.000	0.998	0.002
Y42.2 Antithyroid drugs	0.001	0.998	0.001
M07.36 Other psoriatic arthropathies (Lower leg)	0.000	0.998	0.002
J38.3 Other diseases of vocal cords	0.002	0.998	0.000
M25.75 Osteophyte (Pelvic region and thigh)	0.000	0.998	0.002
S12.21 Fracture of other specified cervical vertebra (open)	0.001	0.998	0.000
C16.2 Body of stomach	0.002	0.998	0.000
S12.8 Fracture of other parts of neck	0.001	0.998	0.000
S12.0 Fracture of first cervical vertebra	0.001	0.998	0.000
S02.30 Fracture of orbital floor (closed)	0.000	0.998	0.002
C16.5 Lesser curvature of stomach, unspecified	0.002	0.998	0.000
C16.4 Pylorus	0.002	0.998	0.000
S02.4 Fracture of malar and maxillary bones	0.000	0.998	0.002
S12.1 Fracture of second cervical vertebra	0.001	0.998	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.001	0.998	0.001
Z87.8 Personal history of other specified conditions	0.000	0.998	0.002
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.002	0.998	0.000
H61.2 Impacted cerumen	0.002	0.998	0.000
J15.8 Other bacterial pneumonia	0.002	0.998	0.000
K35.3 Acute appendicitis with localized peritonitis	0.000	0.998	0.002
S02.7 Multiple fractures involving skull and facial bones	0.000	0.998	0.001
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.001	0.998	0.001
N31 Neuromuscular dysfunction of bladder, not elsewhere classified	0.000	0.998	0.002
S02.61 Fracture of mandible (open)	0.000	0.998	0.001
D50.0 Iron deficiency anaemia secondary to blood loss (chronic)	0.002	0.998	0.000
J15.5 Pneumonia due to Escherichia coli	0.001	0.998	0.000
J43.1 Panlobular emphysema	0.001	0.998	0.000
J43.0 MacLeod's syndrome	0.001	0.998	0.000
K38.8 Other specified diseases of appendix	0.000	0.998	0.002
K35 Acute appendicitis	0.000	0.998	0.002
M07.38 Other psoriatic arthropathies (Other)	0.000	0.998	0.001
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.000	0.998	0.001
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.000	0.998	0.001
M07.34 Other psoriatic arthropathies (Hand)	0.000	0.998	0.001
M07.33 Other psoriatic arthropathies (Forearm)	0.000	0.998	0.001
M07.32 Other psoriatic arthropathies (Upper arm)	0.000	0.998	0.001
M07.31 Other psoriatic arthropathies (Shoulder region)	0.000	0.998	0.001
S12.91 Fracture of neck, part unspecified (open)	0.001	0.998	0.000
H35 Other retinal disorders	0.000	0.998	0.002
S02.31 Fracture of orbital floor (open)	0.000	0.998	0.001
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.001	0.998	0.001
A09.0 Other and unspecified gastroenteritis and colitis of infectious origin	0.000	0.998	0.002
H02.3 Blepharochalasis	0.000	0.998	0.002
J15.1 Pneumonia due to Pseudomonas	0.001	0.998	0.000
S02.5 Fracture of tooth	0.000	0.998	0.001
M23.26 Derangement of meniscus due to old tear or injury (Other and unspecified lateral meniscus)	0.000	0.998	0.002
J20.7 Acute bronchitis due to echovirus	0.001	0.998	0.000
J20.6 Acute bronchitis due to rhinovirus	0.001	0.998	0.000
J20.5 Acute bronchitis due to respiratory syncytial virus	0.001	0.998	0.000
J20.4 Acute bronchitis due to parainfluenza virus	0.001	0.998	0.000
J20.3 Acute bronchitis due to coxsackie virus	0.001	0.998	0.000
J20.2 Acute bronchitis due to streptococcus	0.001	0.998	0.000
J20.1 Acute bronchitis due to Haemophilus influenzae	0.001	0.998	0.000
J20.0 Acute bronchitis due to Mycoplasma pneumoniae	0.001	0.998	0.000
J43.2 Centrilobular emphysema	0.001	0.998	0.000
N31.8 Other neuromuscular dysfunction of bladder	0.000	0.998	0.002
C16.8 Overlapping lesion of stomach	0.001	0.998	0.000
C16.6 Greater curvature of stomach, unspecified	0.001	0.998	0.000
C16.1 Fundus of stomach	0.001	0.998	0.000
J15.9 Bacterial pneumonia, unspecified	0.001	0.998	0.000
O35.9 Maternal care for (suspected) foetal abnormality and damage, unspecified	0.001	0.998	0.000
S02.9 Fracture of skull and facial bones, part unspecified	0.000	0.998	0.001
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.001	0.998	0.001
S13 Dislocation, sprain and strain of joints and ligaments at neck level	0.001	0.998	0.000
S02.11 Fracture of base of skull (open)	0.000	0.999	0.001
C16.0 Cardia	0.001	0.999	0.000
J15.6 Pneumonia due to other aerobic Gram-negative bacteria	0.001	0.999	0.000
J15.3 Pneumonia due to streptococcus, group B	0.001	0.999	0.000
K35.2 Acute appendicitis with generalized peritonitis	0.000	0.999	0.001
T84.8 Other complications of internal orthopaedic prosthetic devices, implants and grafts	0.001	0.999	0.000
M07.39 Other psoriatic arthropathies (Site unspecified)	0.000	0.999	0.001
H35.9 Retinal disorder, unspecified	0.000	0.999	0.001
J15.0 Pneumonia due to Klebsiella pneumoniae	0.001	0.999	0.000
K35.8 Acute appendicitis, other and unspecified	0.000	0.999	0.001
S13.6 Sprain and strain of joints and ligaments of other and unspecified parts of neck	0.001	0.999	0.000
A63 Other predominantly sexually transmitted diseases, not elsewhere classified	0.001	0.999	0.000
K56 Paralytic ileus and intestinal obstruction without hernia	0.000	0.999	0.001
S02.10 Fracture of base of skull (closed)	0.000	0.999	0.001
S12.01 Fracture of first cervical vertebra (open)	0.001	0.999	0.000
S12.00 Fracture of first cervical vertebra (closed)	0.001	0.999	0.000
S12.11 Fracture of second cervical vertebra (open)	0.001	0.999	0.000
S12.81 Fracture of other parts of neck (open)	0.001	0.999	0.000
S12.80 Fracture of other parts of neck (closed)	0.001	0.999	0.000
S02.41 Fracture of malar and maxillary bones (open)	0.000	0.999	0.001
S02.71 Multiple fractures involving skull and facial bones (open)	0.000	0.999	0.001
J20.8 Acute bronchitis due to other specified organisms	0.001	0.999	0.000
N31.0 Uninhibited neuropathic bladder, not elsewhere classified	0.000	0.999	0.001
S02.0 Fracture of vault of skull	0.000	0.999	0.001
J80 Adult respiratory distress syndrome	0.000	0.999	0.001
B37.8 Candidiasis of other sites	0.000	0.999	0.001
E06.3 Autoimmune thyroiditis	0.000	0.999	0.001
H35.0 Background retinopathy and retinal vascular changes	0.000	0.999	0.001
K56.0 Paralytic ileus	0.000	0.999	0.001
S12.10 Fracture of second cervical vertebra (closed)	0.001	0.999	0.000
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.001	0.999	0.000
H35.1 Retinopathy of prematurity	0.000	0.999	0.001
K38.1 Appendicular concretions	0.000	0.999	0.001
R47.8 Other and unspecified speech disturbances	0.000	0.999	0.001
H61 Other disorders of external ear	0.001	0.999	0.000
K38 Other diseases of appendix	0.000	0.999	0.001
M25.71 Osteophyte (Shoulder region)	0.000	0.999	0.001
M88.90 Paget's disease of bone, unspecified (Multiple sites)	0.000	0.999	0.001
S02.51 Fracture of tooth (open)	0.000	0.999	0.001
O26.9 Pregnancy-related condition, unspecified	0.001	0.999	0.000
Z98.2 Presence of cerebrospinal fluid drainage device	0.001	0.999	0.000
M80.90 Unspecified osteoporosis with pathological fracture (Multiple sites)	0.001	0.999	0.000
S02.91 Fracture of skull and facial bones, part unspecified (open)	0.000	0.999	0.001
H25.1 Senile nuclear cataract	0.000	0.999	0.001
R56.8 Other and unspecified convulsions	0.000	0.999	0.001
S13.5 Sprain and strain of thyroid region	0.001	0.999	0.000
S13.3 Multiple dislocations of neck	0.001	0.999	0.000
S13.2 Dislocation of other and unspecified parts of neck	0.001	0.999	0.000
S13.0 Traumatic rupture of cervical intervertebral disk	0.001	0.999	0.000
A02.0 Salmonella gastro-enteritis	0.000	0.999	0.001
H17.9 Corneal scar and opacity, unspecified	0.001	0.999	0.000
N90.4 Leukoplakia of vulva	0.000	0.999	0.001
Z95.4 Presence of other heart-valve replacement	0.000	0.999	0.001
A04 Other bacterial intestinal infections	0.000	0.999	0.001
A04.9 Bacterial intestinal infection, unspecified	0.000	0.999	0.001
A63.8 Other specified predominantly sexually transmitted diseases	0.001	0.999	0.000
K38.9 Disease of appendix, unspecified	0.000	0.999	0.001
K56.3 Gallstone ileus	0.000	0.999	0.001
N31.1 Reflex neuropathic bladder, not elsewhere classified	0.000	0.999	0.001
T43.3 Phenothiazine antipsychotics and neuroleptics	0.001	0.999	0.000
Y42.7 Androgens and anabolic congeners	0.000	0.999	0.001
S02.70 Multiple fractures involving skull and facial bones (closed)	0.000	0.999	0.001
S02.01 Fracture of vault of skull (open)	0.000	0.999	0.001
S02.40 Fracture of malar and maxillary bones (closed)	0.000	0.999	0.001
L28.0 Lichen simplex chronicus	0.001	0.999	0.000
N31.2 Flaccid neuropathic bladder, not elsewhere classified	0.000	0.999	0.001
M25.77 Osteophyte (Ankle and foot)	0.000	0.999	0.001
K38.3 Fistula of appendix	0.000	0.999	0.001
K38.2 Diverticulum of appendix	0.000	0.999	0.001
K38.0 Hyperplasia of appendix	0.000	0.999	0.001
S13.1 Dislocation of cervical vertebra	0.001	0.999	0.000
H60-H62 Diseases of external ear	0.001	0.999	0.000
C21.1 Anal canal	0.001	0.999	0.000
E23.0 Hypopituitarism	0.000	0.999	0.001
F12.1 Harmful use	0.000	0.999	0.001
G47.8 Other sleep disorders	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations